By Oscar Mairena, Manager of Viral Hepatitis and Policy and Legislative Affairs, NASTAD

Oscar Mairena, Manager, Viral Hepatitis/Policy and Legislative Affairs, NASTAD
This weekend marks the third anniversary of the passage of the Patient Protection and Affordable Care Act (ACA). The ACA improves access to care and preventive services through expansion of public and private insurance, reforms that eliminate discriminatory insurance practices and make insurance coverage more affordable, and significant investments in prevention, care coordination, and health workforce and infrastructure. In the case of viral hepatitis, the ACA provides an opportunity to not only improve access to essential care and treatment for people living with viral hepatitis, but to diagnose viral hepatitis earlier and prevent new infections. In light of the ACA’s anniversary, NASTAD released a primer today on viral hepatitis and the ACA, The Affordable Care Act and the Silent Epidemic: Increasing the Viral Hepatitis Response through Health Reform. The primer provides an overview of how health reform impacts viral hepatitis prevention, screening, linkage and retention to care, and treatment.
Continue reading →